Covid-19 – Page 84 – REGENHEALTHSOLUTIONS (RHS)

PIER MARIA FORNASARI
2020-03-17

Melbourne researchers have mapped immune responses from one of Australia’s first novel COVID-19 patients, showing the body’s ability to fight the virus and recover from the infection.

Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) were able to test blood samples at four different time points in an otherwise healthy woman in her 40s, who presented with COVID-19 and had mild-to-moderate symptoms requiring hospital admission. Published today in Nature Medicine is a detailed report of how the patient’s immune system

No Comments InCovid-19

PIER MARIA FORNASARI
2020-03-16

Asymptomatic patients can be responsible for vast majority of cases, study says

The explosive spread of the coronavirus in Wuhan, China, was driven by people whose disease was never diagnosed, a new study has found, suggesting that people with symptoms so mild that they may not have known they were sick unwittingly spread disease in China and ultimately around the world. Jeffrey Shaman, an infectious-disease expert at Columbia

No Comments InCovid-19

PIER MARIA FORNASARI
2020-03-14

Worst-case coronavirus scenario published by disease modelers of CDC: 214 million Americans infected, 1.7 million dead

The worst-case figures are what would happen if no action is taken to slow the virus, which spreads person to person. Disease modelers at the US Centers for Disease Control and Prevention project that as much as 65% of the American population could eventually be infected by the new coronavirus, according to the New York Times.

No Comments InCovid-19

PIER MARIA FORNASARI
2020-03-14

Why patients with hypertension, diabetes mellitus and ibuprofen usage could be at increased risk for COVID-19 infection?

A letter, recently published on Lancet, suggests that ACE inhibitors, ARBs and ibuprofen results in upregulation of ACE2 receptors. Human pathogenic coronaviruses (severe acute respiratory syndrome coronavirus [SARS-CoV] and SARSCoV-2) bind to their target cells through angiotensin-converting enzyme 2 (ACE2), which is expressed by epithelial cells of the lung, intestine, kidney, and blood vessels. The

No Comments InCovid-19

PIER MARIA FORNASARI
2020-03-14

Infectious Disease Experts Recommend Using Antibodies from COVID-19 Survivors as Stopgap Measure to Treat Patients and Protect Healthcare Workers

INFUSIONS OF ANTIBODY-LADEN BLOOD HAVE BEEN USED WITH REPORTED SUCCESS IN PRIOR OUTBREAKS, INCLUDING THE SARS EPIDEMIC AND THE 1918 FLU PANDEMIC Countries fighting outbreaks of the novel coronavirus disease COVID-19 should consider using the antibodies of people who have recovered from infection to treat cases and provide short-term immunity—lasting weeks to months—to critical health care

No Comments InCovid-19

PIER MARIA FORNASARI
2020-03-13

Pluristem and Charité University of Medicine Berlin Join Forces Targeting Potential Treatment for Respiratory and Inflammatory Intratissue Complications Caused by COVID-19

Pluristem Therapeutics Inc., a leading regenerative medicine company developing a platform of novel biological products, today announced it has signed a collaborative agreement with the BIH Center for Regenerative Therapy (BCRT) and the Berlin Center for Advanced Therapies (BeCAT) at Charite’ University of Medicine Berlin to expand its existing framework and research agreement and conduct

No Comments InCovid-19

PIER MARIA FORNASARI
2020-03-13

COVID-19 and Italy: what next? A new modelling study published on Lancet

Coronavirus statistics: is Italy the new China? After several weeks of fighting the epidemic, the situation in China finally seems to come back under control. But can we say that even in our country we will see similar results? How are they similar and how do their situations differ? We therefore report the statistics on

No Comments InCovid-19

REGENERATIVE AND PERSONALISED MEDICINE

DIGITAL HEALTHCARE

Category Covid-19

Melbourne researchers have mapped immune responses from one of Australia’s first novel COVID-19 patients, showing the body’s ability to fight the virus and recover from the infection.

Asymptomatic patients can be responsible for vast majority of cases, study says

Worst-case coronavirus scenario published by disease modelers of CDC: 214 million Americans infected, 1.7 million dead

Why patients with hypertension, diabetes mellitus and ibuprofen usage could be at increased risk for COVID-19 infection?

Infectious Disease Experts Recommend Using Antibodies from COVID-19 Survivors as Stopgap Measure to Treat Patients and Protect Healthcare Workers

Pluristem and Charité University of Medicine Berlin Join Forces Targeting Potential Treatment for Respiratory and Inflammatory Intratissue Complications Caused by COVID-19

COVID-19 and Italy: what next? A new modelling study published on Lancet